Ready to play
Ready to play
Ain Shams University has launched targeted nuclear therapy for prostate cancer using Theranostics technology for the first time in university hospitals in Egypt. This approach relies on precise targeting of PSMA receptors to direct treatment specifically to tumors and sites of spread. The therapy involves the use of Lu-177 PSMA and aims to improve treatment options for patients who have exhausted other possibilities, with several free doses offered in collaboration with supporting organizations. Medical staff have been trained on this new technique, enhancing the localization of advanced technologies, supporting scientific research, and improving healthcare services for cancer patients.
Notice: This Is an AI-Generated Summary
Comments (0)